Stenocare

1.3

DKK

-7.14 %

STENO

First North Denmark

Biotechnology & Pharmaceuticals

Health Care

6 following

-7.14%

-35.64%

-45.83%

-67.5%

-48.82%

-57.24%

-87.3%

-95.42%

-94.68%

Stenocare is a Danish supplier of medical cannabis. Stenocare is the first player to have started sale of medical cannabis-based oils in Denmark. The company is now looking towards further European markets for its products. Stenocare is based in Randers, Denmark.

Market cap

26.28M DKK

Turnover

101K DKK

Revenue

6.92M

EBIT %

-230.49 %

P/E

-

Dividend yield-%

-

Financial calendar

27.2

2025

Annual report '24

8.5

2025

Interim report Q1'25

21.8

2025

Interim report Q2'25

ShowingAll content types

Regulatory press release12/18/2024, 6:00 PM

STENOCARE A/S: Conditional Rights Issue of up to 20.2 mDKK

Regulatory press release12/18/2024, 12:37 PM

Communiqué from extraordinary general meeting in STENOCARE

Press release12/17/2024, 7:00 AM

STENOCARE Gains Danish Approval for New Medical Cannabis CBD100 oil

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release12/10/2024, 2:38 PM

STENOCARE 3.0 Strategy: Management Shares Insights in Exclusive Interview with Proinvestor.com

Press release12/2/2024, 7:00 AM

STENOCARE - Innovative New ASTRUM Product Officially Approved for Sale in Norway

Press release11/28/2024, 9:14 PM

STENOCARE Celebrates Denmark's Permanent Legalisation of Medical Cannabis

Regulatory press release11/26/2024, 4:46 PM

STENOCARE 3.0: Shifting Strategy to Focus on Trading and exit from Production

Regulatory press release11/26/2024, 4:11 PM

Notice to Extraordinary General Meeting in STENOCARE A/S

Press release11/19/2024, 12:36 PM

STENOCARE Hylder Den Danske Sundhedsministers Beslutning om Permanent Legalisering af Medicinsk Cannabis

Press release11/19/2024, 12:09 PM

STENOCARE Welcomes Danish Health Minister's Decision to Permanently Legalise Medical Cannabis for Patients

Regulatory press release11/5/2024, 12:31 PM

STENOCARE: Interim Report Third Quarter 2024

Regulatory press release11/1/2024, 12:31 PM

STENOCARE Change in the Board of Directors

Regulatory press release10/14/2024, 6:00 AM

STENOCARE updates guidance for 2024

Regulatory press release8/21/2024, 6:00 AM

STENOCARE: Interim Report Second Quarter 2024

Regulatory press release8/20/2024, 6:00 AM

STENOCARE updates guidance for 2024

Press release7/31/2024, 1:40 PM

STENOCARE: New innovative Stenocare Astrum 10-10 oil product is ready for sale in Germany

Regulatory press release6/28/2024, 3:17 PM

STENOCARE A/S: Directed issue, refinancing of debt from a major shareholder and new dates

Regulatory press release6/25/2024, 12:01 PM

STENOCARE: TO2 Warrant Exercise subscribed to 88.3%

Press release6/20/2024, 6:00 AM

STENOCARE: Notice for deadline of subscribing at the discounted price of DKK 3.16 per share

Press release6/18/2024, 11:31 AM

STENOCARE A/S: Notice for deadline of trading TO2 Warrants

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.